CT-guided 125I brachytherapy for hepatocellular carcinoma in high-risk locations after transarterial chemoembolization combined with microwave ablation: a propensity score-matched study
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71: 209-49. doi: 10.3322/caac.21660SungHFerlayJSiegelRLLaversanneMSoerjomataramIJemalAet alGlobal Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries20217120949doi10.3322/caac.21660Open DOISearch in Google Scholar
Hepatocellular carcinoma. Nat Rev Dis Primers 2021; 7: 7. doi: 10.1038/s41572-021-00245-6Hepatocellular carcinoma202177doi10.1038/s41572-021-00245-6Open DOISearch in Google Scholar
European Association for the Study of the Liver. Electronic address, European Association for the Study of the L. EASL Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol 2018; 69: 182-236. doi: 10.1016/j.jhep.2018.03.019European Association for the Study of the LiverElectronic address, European Association for the Study of the L. EASL Clinical Practice Guidelines: management of hepatocellular carcinoma201869182236doi10.1016/j.jhep.2018.03.019Open DOISearch in Google Scholar
Reig M, Forner A, Rimola J, Ferrer-Fabrega J, Burrel M, Garcia-Criado A, et al. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. J Hepatol 2022; 76: 681-93. doi: 10.1016/j.jhep.2021.11.018ReigMFornerARimolaJFerrer-FabregaJBurrelMGarcia-CriadoAet alBCLC strategy for prognosis prediction and treatment recommendation: the 2022 update20227668193doi10.1016/j.jhep.2021.11.018Open DOISearch in Google Scholar
Takuma Y, Takabatake H, Morimoto Y, Toshikuni N, Kayahara T, Makino Y, et al. Comparison of combined transcatheter arterial chemoembolization and radiofrequency ablation with surgical resection by using propensity score matching in patients with hepatocellular carcinoma within Milan criteria. Radiology 2013; 269: 927-37. doi: 10.1148/radiol.13130387TakumaYTakabatakeHMorimotoYToshikuniNKayaharaTMakinoYet alComparison of combined transcatheter arterial chemoembolization and radiofrequency ablation with surgical resection by using propensity score matching in patients with hepatocellular carcinoma within Milan criteria201326992737doi10.1148/radiol.13130387Open DOISearch in Google Scholar
Li W, Ni CF. Current status of the combination therapy of transarterial chemoembolization and local ablation for hepatocellular carcinoma. Abdom Radiol 2019; 44: 2268-75. doi: 10.1007/s00261-019-01943-2LiWNiCFCurrent status of the combination therapy of transarterial chemoembolization and local ablation for hepatocellular carcinoma201944226875doi10.1007/s00261-019-01943-2Open DOISearch in Google Scholar
Peng Z, Chen S, Wei M, Lin M, Jiang C, Mei J, et al. Advanced recurrent hepatocellular carcinoma: treatment with sorafenib alone or in combination with transarterial chemoembolization and radiofrequency ablation. Radiology 2018; 287: 705-14. doi: 10.1148/radiol.2018171541PengZChenSWeiMLinMJiangCMeiJet alAdvanced recurrent hepatocellular carcinoma: treatment with sorafenib alone or in combination with transarterial chemoembolization and radiofrequency ablation201828770514doi10.1148/radiol.2018171541Open DOISearch in Google Scholar
Peng ZW, Zhang YJ, Liang HH, Lin XJ, Guo RP, Chen MS. Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial. Radiology 2012; 262: 689-700. doi: 10.1148/radiol.11110637PengZWZhangYJLiangHHLinXJGuoRPChenMSRecurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial2012262689700doi10.1148/radiol.11110637Open DOISearch in Google Scholar
Seki T, Tamai T, Nakagawa T, Imamura M, Nishimura A, Yamashiki N, et al. Combination therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinoma. Cancer 2000; 89: 1245-51. PMID: 11002219SekiTTamaiTNakagawaTImamuraMNishimuraAYamashikiNet alCombination therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinoma200089124551PMID: 11002219Search in Google Scholar
Li Z, Jiao D, Han X, Si G, Li Y, Liu J, et al. Transcatheter arterial chemoembolization combined with simultaneous DynaCT-guided microwave ablation in the treatment of small hepatocellular carcinoma. Cancer Imaging 2020; 20: 13. doi: 10.1186/s40644-020-0294-5LiZJiaoDHanXSiGLiYLiuJet alTranscatheter arterial chemoembolization combined with simultaneous DynaCT-guided microwave ablation in the treatment of small hepatocellular carcinoma20202013doi10.1186/s40644-020-0294-5Open DOISearch in Google Scholar
Zaitoun MMA, Elsayed SB, Zaitoun NA, Soliman RK, Elmokadem AH, Farag AA, et al. Combined therapy with conventional trans-arterial chemoembolization (cTACE) and microwave ablation (MWA) for hepatocellular carcinoma >3-<5 cm. Int J Hyperthermia 2021; 38: 248-56. doi: 10.1080/02656736.2021.1887941ZaitounMMAElsayedSBZaitounNASolimanRKElmokademAHFaragAAet alCombined therapy with conventional trans-arterial chemoembolization (cTACE) and microwave ablation (MWA) for hepatocellular carcinoma >3-<5 cm20213824856doi10.1080/02656736.2021.1887941Open DOISearch in Google Scholar
Liu C, Liang P, Liu F, Wang Y, Li X, Han Z, et al. MWA combined with TACE as a combined therapy for unresectable large-sized hepotocellular carcinoma. Int J Hyperthermia 2011; 27: 654-62. doi: 10.3109/02656736.2011.605099LiuCLiangPLiuFWangYLiXHanZet alMWA combined with TACE as a combined therapy for unresectable large-sized hepotocellular carcinoma20112765462doi10.3109/02656736.2011.605099Open DOISearch in Google Scholar
Shi F, Wu M, Lian SS, Mo ZQ, Gou Q, Xu RD, et al. Radiofrequency ablation following downstaging of hepatocellular carcinoma by using transarterial chemoembolization: Long-term outcomes. Radiology 2019; 293: 707-15. doi: 10.1148/radiol.2019181991ShiFWuMLianSSMoZQGouQXuRDet alRadiofrequency ablation following downstaging of hepatocellular carcinoma by using transarterial chemoembolization: Long-term outcomes201929370715doi10.1148/radiol.2019181991Open DOISearch in Google Scholar
Peng ZW, Zhang YJ, Chen MS, Xu L, Liang HH, Lin XJ, et al. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. J Clin Oncol 2013; 31: 426-32. doi: 10.1200/JCO.2012.42.9936PengZWZhangYJChenMSXuLLiangHHLinXJet alRadiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial20133142632doi10.1200/JCO.2012.42.9936Open DOISearch in Google Scholar
Facciorusso A, Di Maso M, Muscatiello N. Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma: a systematic review and meta-analysis. Int J Hyperthermia 2016; 32: 339-44. doi: 10.3109/02656736.2015.1127434FacciorussoADi MasoMMuscatielloNMicrowave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma: a systematic review and meta-analysis20163233944doi10.3109/02656736.2015.1127434Open DOISearch in Google Scholar
Llovet JM, De Baere T, Kulik L, Haber PK, Greten TF, Meyer T, et al. Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 2021; 18: 293-313. doi: 10.1038/s41575-020-00395-0LlovetJMDe BaereTKulikLHaberPKGretenTFMeyerTet alLocoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma202118293-313doi10.1038/s41575-020-00395-0Open DOISearch in Google Scholar
Lu DS, Raman SS, Vodopich DJ, Wang M, Sayre J, Lassman C. Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the “heat sink” effect. AJR Am J Roentgenol 2002; 178: 47-51. doi: 10.2214/ajr.178.1.1780047LuDSRamanSSVodopichDJWangMSayreJLassmanCEffect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the “heat sink” effect20021784751doi10.2214/ajr.178.1.1780047Open DOISearch in Google Scholar
Zheng H, Liu K, Yang Y, Liu B, Zhao X, Chen Y, et al. Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score-matched study. Eur Radiol 2022. 32: 4657-66. doi: 10.1007/s00330-022-08537-5ZhengHLiuKYangYLiuBZhaoXChenYet alMicrowave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score-matched study202232465766doi10.1007/s00330-022-08537-5Open DOISearch in Google Scholar
An C, Li WZ, Huang ZM, Yu XL, Han YZ, Liu FY, et al. Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis. Eur Radiol 2021; 31: 4764-73. doi: 10.1007/s00330-020-07571-5AnCLiWZHuangZMYuXLHanYZLiuFYet alSmall single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis202131476473doi10.1007/s00330-020-07571-5Open DOISearch in Google Scholar
Li Q, Ao GK, Duan F, Wang ZJ, Yan JY, Wang MQ. Incidence and therapeutic frequency of extrahepatic collateral arteries in transcatheter arterial chemoembolization of hepatocellular carcinoma: experience from 182 patients with survival time more than 3 years. Eur J Radiol 2015; 84: 2555-63. doi: 10.1016/j.ejrad.2015.10.006LiQAoGKDuanFWangZJYanJYWangMQIncidence and therapeutic frequency of extrahepatic collateral arteries in transcatheter arterial chemoembolization of hepatocellular carcinoma: experience from 182 patients with survival time more than 3 years201584255563doi10.1016/j.ejrad.2015.10.006Open DOISearch in Google Scholar
Zelefsky MJ, Wallner KE, Ling CC, Raben A, Hollister T, Wolfe T, et al. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer. J Clin Oncol 1999; 17: 517-22. doi: 10.1200/jco.1999.17.2.517ZelefskyMJWallnerKELingCCRabenAHollisterTWolfeTet alComparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer19991751722doi10.1200/jco.1999.17.2.517Open DOISearch in Google Scholar
Chen K, Chen G, Wang H, Li H, Xiao J, Duan X, et al. Increased survival in hepatocellular carcinoma with iodine-125 implantation plus radiofrequency ablation: a prospective randomized controlled trial. J Hepatol 2014; 61: 1304-11. doi: 10.1016/j.jhep.2014.07.026ChenKChenGWangHLiHXiaoJDuanXet alIncreased survival in hepatocellular carcinoma with iodine-125 implantation plus radiofrequency ablation: a prospective randomized controlled trial201461130411doi10.1016/j.jhep.2014.07.026Open DOISearch in Google Scholar
Wang G, Zhang F, Yang B, Xue J, Peng S, Zhong Z, et al. Feasibility and clinical value of CT-guided (125)I brachytherapy for bilateral lung recurrences from colorectal carcinoma. Radiology 2016; 278: 897-905. doi: 10.1148/radiol.2015150641WangGZhangFYangBXueJPengSZhongZet alFeasibility and clinical value of CT-guided (125)I brachytherapy for bilateral lung recurrences from colorectal carcinoma2016278897905doi10.1148/radiol.2015150641Open DOISearch in Google Scholar
Ruge MI, Simon T, Suchorska B, Lehrke R, Hamisch C, Koerber F, et al. Stereotactic brachytherapy with iodine-125 seeds for the treatment of inoperable low-grade gliomas in children: long-term outcome. J Clin Oncol 2011; 29: 4151-9. doi: 10.1200/JCO.2011.37.3381RugeMISimonTSuchorskaBLehrkeRHamischCKoerberFet alStereotactic brachytherapy with iodine-125 seeds for the treatment of inoperable low-grade gliomas in children: long-term outcome20112941519doi10.1200/JCO.2011.37.3381Open DOISearch in Google Scholar
Ren Y, Dong X, Chen L, Sun T, Alwalid O, Kan X, et al. Combined ultrasound and CT-guided Iodine-125 seeds implantation for treatment of residual hepatocellular carcinoma located at complex sites after transcatheter arterial chemoembolization. Front Oncol 2021; 11: 582544. doi: 10.3389/fonc.2021.582544RenYDongXChenLSunTAlwalidOKanXet alCombined ultrasound and CT-guided Iodine-125 seeds implantation for treatment of residual hepatocellular carcinoma located at complex sites after transcatheter arterial chemoembolization202111582544doi10.3389/fonc.2021.582544Open DOISearch in Google Scholar
Lin ZY, Chen J, Deng XF. Treatment of hepatocellular carcinoma adjacent to large blood vessels using 1.5T MRI-guided percutaneous radiofrequency ablation combined with iodine-125 radioactive seed implantation. Eur J Radiol 2012; 81: 3079-83. doi: 10.1016/j.ejrad.2012.05.007LinZYChenJDengXFTreatment of hepatocellular carcinoma adjacent to large blood vessels using 1.5T MRI-guided percutaneous radiofrequency ablation combined with iodine-125 radioactive seed implantation201281307983doi10.1016/j.ejrad.2012.05.007Open DOISearch in Google Scholar
Gao FL, Wang Y, Huang XZ, Pan TF, Guo JH. I-125 seeds brachytherapy with transcatheter arterial chemoembolization for subcapsular hepatocellular carcinoma. BMC Gastroenterol 2022; 22: 273. doi: 10.1186/s12876-022-02356-0GaoFLWangYHuangXZPanTFGuoJHI-125 seeds brachytherapy with transcatheter arterial chemoembolization for subcapsular hepatocellular carcinoma202222273doi10.1186/s12876-022-02356-0Open DOISearch in Google Scholar
Wang W, Wang C, Shen J, Ren B, Yin Y, Yang J, et al. Integrated I-125 seed implantation combined with transarterial chemoembolization for treatment of hepatocellular carcinoma with main portal vein tumor thrombus. Cardiovasc Intervent Radiol 2021; 44: 1570-8. doi: 10.1007/s00270-021-02887-1WangWWangCShenJRenBYinYYangJet alIntegrated I-125 seed implantation combined with transarterial chemoembolization for treatment of hepatocellular carcinoma with main portal vein tumor thrombus20214415708doi10.1007/s00270-021-02887-1Open DOISearch in Google Scholar
Austin PC. The relative ability of different propensity score methods to balance measured covariates between treated and untreated subjects in observational studies. Med Decis Making 2009; 29: 661-77. doi: 10.1177/0272989x09341755AustinPCThe relative ability of different propensity score methods to balance measured covariates between treated and untreated subjects in observational studies20092966177doi10.1177/0272989x09341755Open DOISearch in Google Scholar
Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassis MM, Roberts LR, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 2018; 67: 358-80. doi: 10.1002/hep.29086HeimbachJKKulikLMFinnRSSirlinCBAbecassisMMRobertsLRet alAASLD guidelines for the treatment of hepatocellular carcinoma20186735880doi10.1002/hep.29086Open DOISearch in Google Scholar
Teratani T, Yoshida H, Shiina S, Obi S, Sato S, Tateishi R, et al. Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations. Hepatology 2006; 43: 1101-8. doi: 10.1002/hep.21164TerataniTYoshidaHShiinaSObiSSatoSTateishiRet alRadiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations20064311018doi10.1002/hep.21164Open DOISearch in Google Scholar
Lin JW, Lin CC, Chen WT, Lin SM. Combining radiofrequency ablation and ethanol injection may achieve comparable long-term outcomes in larger hepatocellular carcinoma (3.1-4 cm) and in high-risk locations. Kaohsiung J Med Sci 2014; 30: 396-401. doi: 10.1016/j.kjms.2014.04.006LinJWLinCCChenWTLinSMCombining radiofrequency ablation and ethanol injection may achieve comparable long-term outcomes in larger hepatocellular carcinoma (3.1-4 cm) and in high-risk locations201430396401doi10.1016/j.kjms.2014.04.006Open DOISearch in Google Scholar
Llovet JM, Lencioni R. mRECIST for HCC: Performance and novel refinements. J Hepatol 2020; 72: 288-306. doi: 10.1016/j.jhep.2019.09.026LlovetJMLencioniRmRECIST for HCC: Performance and novel refinements202072288306doi10.1016/j.jhep.2019.09.026Open DOISearch in Google Scholar
Hong D, Zhou Y, Wan X, Su H, Shao H. Brachytherapy with Iodine-125 seeds for treatment of portal vein-branch tumor thrombus in patients with hepatocellular carcinoma. BMC Cancer 2021; 21: 1020. doi: 10.1186/s12885-021-08680-0HongDZhouYWanXSuHShaoHBrachytherapy with Iodine-125 seeds for treatment of portal vein-branch tumor thrombus in patients with hepatocellular carcinoma2021211020doi10.1186/s12885-021-08680-0Open DOISearch in Google Scholar
Vogel A, Cervantes A, Chau I, Daniele B, Llovet JM, Meyer T, et al. Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2018; 29: iv238-iv55. doi: 10.1093/annonc/mdy308VogelACervantesAChauIDanieleBLlovetJMMeyerTet alHepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up201829iv238iv55doi10.1093/annonc/mdy308Open DOISearch in Google Scholar
Chen J, Peng K, Hu D, Shen J, Zhou Z, Xu L, et al. Tumor location influences oncologic outcomes of hepatocellular carcinoma patients undergoing radiofrequency ablation. Cancers 2018; 10. 501. doi: 10.3390/cancers10100378ChenJPengKHuDShenJZhouZXuLet alTumor location influences oncologic outcomes of hepatocellular carcinoma patients undergoing radiofrequency ablation201810501doi10.3390/cancers10100378Open DOISearch in Google Scholar
Zhang TQ, Huang ZM, Shen JX, Chen GQ, Shen LJ, Ai F, et al. Safety and effectiveness of multi-antenna microwave ablation-oriented combined therapy for large hepatocellular carcinoma. Therap Adv Gastroenterol 2019; 12: 1756284819862966. doi: 10.1177/1756284819862966ZhangTQHuangZMShenJXChenGQShenLJAiFet alSafety and effectiveness of multi-antenna microwave ablation-oriented combined therapy for large hepatocellular carcinoma2019121756284819862966doi10.1177/1756284819862966Open DOISearch in Google Scholar
DeWeese TL, Shipman JM, Dillehay LE, Nelson WG. Sensitivity of human prostatic carcinoma cell lines to low dose rate radiation exposure. J Urol 1998; 159: 591-8. doi: 10.1016/s0022-5347(01)63990-9DeWeeseTLShipmanJMDillehayLENelsonWGSensitivity of human prostatic carcinoma cell lines to low dose rate radiation exposure19981595918doi10.1016/s0022-5347(01)63990-9Open DOISearch in Google Scholar
Koritzinsky M, Wouters BG, Amellem O, Pettersen EO. Cell cycle progression and radiation survival following prolonged hypoxia and re-oxygenation. Int J Radiat Biol 2001; 77: 319-28. doi: 10.1080/09553000010019278KoritzinskyMWoutersBGAmellemOPettersenEOCell cycle progression and radiation survival following prolonged hypoxia and re-oxygenation20017731928doi10.1080/09553000010019278Open DOISearch in Google Scholar
Grieco CA, Simon CJ, Mayo-Smith WW, DiPetrillo TA, Ready NE, Dupuy DE. Percutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer. J Vasc Interv Radiol 2006; 17: 1117-24. doi: 10.1097/01.Rvi.0000228373.58498.6eGriecoCASimonCJMayo-SmithWWDiPetrilloTAReadyNEDupuyDEPercutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer200617111724doi10.1097/01.Rvi.0000228373.58498.6eOpen DOISearch in Google Scholar
Kang TW, Lim HK, Lee MW, Kim YS, Choi D, Rhim H. Perivascular versus nonperivascular small HCC treated with percutaneous RF ablation: retrospective comparison of long-term therapeutic outcomes. Radiology 2014; 270: 888-99. doi: 10.1148/radiol.13130753KangTWLimHKLeeMWKimYSChoiDRhimHPerivascular versus nonperivascular small HCC treated with percutaneous RF ablation: retrospective comparison of long-term therapeutic outcomes201427088899doi10.1148/radiol.13130753Open DOISearch in Google Scholar
Kang TW, Lim HK, Lee MW, Kim YS, Rhim H, Lee WJ, et al. Long-term therapeutic outcomes of radiofrequency ablation for subcapsular versus non-subcapsular hepatocellular carcinoma: a propensity score matched study. Radiology 2016; 280: 300-12. doi: 10.1148/radiol.2016151243KangTWLimHKLeeMWKimYSRhimHLeeWJet alLong-term therapeutic outcomes of radiofrequency ablation for subcapsular versus non-subcapsular hepatocellular carcinoma: a propensity score matched study201628030012doi10.1148/radiol.2016151243Open DOISearch in Google Scholar
Formenti SC, Demaria S. Systemic effects of local radiotherapy. Lancet Oncol 2009; 10: 718-26. doi: 10.1016/s1470-2045(09)70082-8FormentiSCDemariaSSystemic effects of local radiotherapy20091071826doi10.1016/s1470-2045(09)70082-8Open DOISearch in Google Scholar
De Palma M, Coukos G, Hanahan D. A new twist on radiation oncology: low-dose irradiation elicits immunostimulatory macrophages that unlock barriers to tumor immunotherapy. Cancer Cell 2013; 24: 559-61. doi: 10.1016/j.ccr.2013.10.019De PalmaMCoukosGHanahanDA new twist on radiation oncology: low-dose irradiation elicits immunostimulatory macrophages that unlock barriers to tumor immunotherapy20132455961doi10.1016/j.ccr.2013.10.019Open DOISearch in Google Scholar
Hu HT, Luo JP, Cao GS, Li Z, Jiang M, Guo CY, et al. Hepatocellular carcinoma with portal vein tumor thrombus treated with transarterial chemoembolization and sorafenib vs. (125)Iodine implantation. Front Oncol 2021; 11: 806907. doi: 10.3389/fonc.2021.806907HuHTLuoJPCaoGSLiZJiangMGuoCYet alHepatocellular carcinoma with portal vein tumor thrombus treated with transarterial chemoembolization and sorafenib vs. (125)Iodine implantation202111806907doi10.3389/fonc.2021.806907Open DOISearch in Google Scholar
Yang M, Fang Z, Yan Z, Luo J, Liu L, Zhang W, et al. Transarterial chemoembolisation (TACE) combined with endovascular implantation of an iodine-125 seed strand for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis versus TACE alone: a two-arm, randomised clinical trial. J Cancer Res Clin Oncol 2014; 140: 211-9. doi: 10.1007/s00432-013-1568-0YangMFangZYanZLuoJLiuLZhangWet alTransarterial chemoembolisation (TACE) combined with endovascular implantation of an iodine-125 seed strand for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis versus TACE alone: a two-arm, randomised clinical trial20141402119doi10.1007/s00432-013-1568-0Open DOISearch in Google Scholar
Lee J, Shin IS, Yoon WS, Koom WS, Rim CH. Comparisons between radiofrequency ablation and stereotactic body radiotherapy for liver malignancies: meta-analyses and a systematic review. Radiother Oncol 2020; 145: 63-70. doi: 10.1016/j.radonc.2019.12.004LeeJShinISYoonWSKoomWSRimCHComparisons between radiofrequency ablation and stereotactic body radiotherapy for liver malignancies: meta-analyses and a systematic review20201456370doi10.1016/j.radonc.2019.12.004Open DOISearch in Google Scholar